TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 52 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,342,000 | -43.5% | 665,900 | +1.0% | 0.05% | -27.9% |
| Q4 2021 | $7,679,000 | -36.6% | 659,100 | +1.3% | 0.07% | -35.8% |
| Q3 2021 | $12,114,000 | -16.4% | 650,600 | -4.8% | 0.11% | -10.9% |
| Q2 2021 | $14,488,000 | +79.7% | 683,400 | +72.1% | 0.12% | +72.5% |
| Q1 2021 | $8,063,000 | -28.4% | 397,200 | -6.4% | 0.07% | -24.2% |
| Q4 2020 | $11,264,000 | +20.4% | 424,400 | +1.6% | 0.09% | +3.4% |
| Q3 2020 | $9,356,000 | – | 417,700 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Investment Advisors, LLC | 10,000 | $17,700 | 0.00% |